Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients-Reference-Cited by-同舟云学术

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients

Published:2003-02 Issue:3 Volume:120 Page:405-412
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Galimberti Sara,Morabito Fortunato,Guerrini Francesca,Palumbo Giuseppe Alberto,Azzará Antonio,Martino Massimo,Benedetti Edoardo,Di Raimondo Francesco,Petrini Mario

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04106.x/fullpdf

Reference23 articles.

1. A prospective, randomized trial of autologous blood stem cell transplantation and chemotherapy in multiple myeloma;Attal;New England Journal of Medicine,1996

2. Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma;Barbui;British Journal of Haematology,2002

3. Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma;Cavo;Blood,2000

4. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells;Corradini;Journal of Clinical Oncology,1999

5. A quantitative PCR assay for the detection of low amounts of malignant cells in multiple myeloma;Cremer;Annals Oncology,1997

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients;Blood Cancer Journal;2023-05-03

2. Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment;Cancers;2020-08-18

3. Bone marrow transplantation generates T cell–dependent control of myeloma in mice;Journal of Clinical Investigation;2018-11-19

4. Minimal residual disease analysis in myeloma – when, why and where;Leukemia & Lymphoma;2017-10-11

5. A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center;Leukemia & Lymphoma;2017-07-03